These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14071825)

  • 1. SENSITIVITY OF NORMAL AND NEOPLASTIC CELLS TO THE DAMAGING ACTION OF CARCINOGENIC SUBSTANCES: A REVIEW.
    VASILIEV JM; GUELSTEIN VI
    J Natl Cancer Inst; 1963 Nov; 31():1123-51. PubMed ID: 14071825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Supposed mutagenic action of carcinogenic substances].
    POLETTINI B; NARPOZZI A
    Boll Soc Ital Biol Sper; 1953 May; 29(5):1064-6. PubMed ID: 13106122
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive resistance of Saccharomyces cerevisiae to chronic treatment with genotoxic and nongenotoxic carcinogens.
    Fahrig R; Fahrig B
    J Environ Pathol Toxicol Oncol; 1999; 18(2):103-8. PubMed ID: 15281221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the origins of the Druckrey-Küpfmüller Papers (1948-1949): dose-effect relations in carcinogenic substances].
    Wunderlich V
    Medizinhist J; 2005; 40(3-4):369-97. PubMed ID: 16382692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
    Leung HW; Kamendulis LM; Stott WT
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis.
    Kawata K; Shimazaki R; Okabe S
    Environ Mol Mutagen; 2009 Jan; 50(1):46-59. PubMed ID: 19031421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacology of carcinogenic substances].
    DRUCKREY H
    Strahlentherapie; 1950; 83(4):597-612. PubMed ID: 14817579
    [No Abstract]   [Full Text] [Related]  

  • 9. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On a possible mechanism of action of carcinogenic substances.
    Olenov JM
    Neoplasma; 1966; 13(4):341-51. PubMed ID: 5331585
    [No Abstract]   [Full Text] [Related]  

  • 11. Modern criteria to determine the etiology of human carcinogens.
    Mossman BT; Klein G; Zur Hausen H
    Semin Cancer Biol; 2004 Dec; 14(6):449-52. PubMed ID: 15489138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYMPOSIUM ON MOLECULAR ACTION OF MUTAGENIC AND CARCINOGENIC AGENTS.
    Lerman LS
    J Cell Comp Physiol; 1964 Oct; 64():SUPPL 1:1-191. PubMed ID: 14218586
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive species: a cell damaging rout assisting to chemical carcinogens.
    Goetz ME; Luch A
    Cancer Lett; 2008 Jul; 266(1):73-83. PubMed ID: 18367325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenic action of some substances which may be a problem in certain future industries.
    BRUES AM; LISCO H; FINKEL MP
    Cancer Res; 1947 Jan; 7(1):48. PubMed ID: 20278227
    [No Abstract]   [Full Text] [Related]  

  • 17. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the sensitivity of the various tissues of an organism to the action of a carcinogen].
    JOYET-LAVERGNE P
    C R Hebd Seances Acad Sci; 1947 Jun; 224(25):1785. PubMed ID: 18896606
    [No Abstract]   [Full Text] [Related]  

  • 20. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
    Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
    Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.